🕵️ Pharmacyte Biotech, Inc. ($PMCB)

SEC insider & ownership activity, last 12 months · CIK 1157075 · every row links its SEC filing

Over the last 12 months insiders bought $129K with no open-market selling against it. Silverman Joshua bought $80K in discretionary trades (Jan). One red-flag 8-K in the window: Delisting notice (3.01), Dec 1, 2025.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$129K Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

2 buyers, $129K (6 lots) · 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Silverman Joshua3$80K 0–Jan 7, 2026
Schechter Jonathan3$48K 0–Jan 7, 2026

5%+ holders

HolderStakeClassScheduleEvent
Ayrton Capital LLC 9.9% 13GFeb 13, 2025 filing ↗
ALTO Opportunity Master Fund, SPC - Segregated Master Portfolio B 9.9% 13GFeb 13, 2025 filing ↗
Waqas Khatri 9.9% 13GFeb 13, 2025 filing ↗

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Officer/director changes (5.02)Mar 30, 2026 filing ↗
Shareholder vote (5.07)Mar 30, 2026 filing ↗
Financial Statements and Exhibits (9.01)Mar 30, 2026 filing ↗
Delisting notice (3.01)Dec 1, 2025 filing ↗
Officer/director changes (5.02)Oct 30, 2025 filing ↗
Shareholder vote (5.07)Oct 30, 2025 filing ↗
Financial Statements and Exhibits (9.01)Oct 30, 2025 filing ↗
Financial Statements and Exhibits (9.01)Sep 2, 2025 filing ↗
Material agreement (1.01)Sep 2, 2025 filing ↗
Acquisition or disposition (2.01)Sep 2, 2025 filing ↗
Reg FD disclosure (7.01)Sep 2, 2025 filing ↗
Financial Statements and Exhibits (9.01)Sep 2, 2025 filing ↗
Material agreement (1.01)Aug 17, 2025 filing ↗
Unregistered equity sale (3.02)Aug 17, 2025 filing ↗
Reg FD disclosure (7.01)Aug 17, 2025 filing ↗
Financial Statements and Exhibits (9.01)Aug 17, 2025 filing ↗